List of insiders holdings for HOOKIPA Pharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
GILEAD SCIENCES INC. 10% Owner | 2023-12-22 16:18:56 | 18,759,465 0 | 18,759,465 | Form 13G |
BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN Former 10% owner | 2024-02-14 16:21:51 | 8,148,985 0 | 8,148,985 | Form 13G |
SOFINNOVA CAPITAL VI FCPR Sofinnova Partners SAS 10% Owner | 2023-02-13 13:34:23 | 3,142,596 0 | 3,142,596 | Form 13D |
Redmile Group LLC Green Jeremy 10% Owner | 2024-02-14 16:26:22 | 1,063,769 0 | 1,063,769 | Form 13G |
Baker Christine D. Chief Operating Officer | 2023-04-18 19:47:32 | 275,800 0 | 275,800 | Form 4 |
Orlinger Klaus Chief Scientific Officer | 2023-04-18 19:50:46 | 194,200 0 | 194,200 | Form 4 |
Schlienger Katia Chief Medical Officer | 2023-04-18 19:48:30 | 184,000 0 | 184,000 | Form 4 |
Pinschewer David Chief Scientific Officer | 2019-04-24 18:14:30 | 116,416 0 | 116,416 | Form 4 |
Necina Roman Chief Development Officer | 2023-04-18 19:49:21 | 112,100 0 | 112,100 | Form 4 |
Matushansky Igor Chief Medical Officer | 2022-07-01 16:11:01 | 92,950 0 | 92,950 | Form 4 |
Aldag Jorn Chief Executive Officer | 2023-07-11 18:21:51 | 71,952 0 | 71,952 | Form 4 |
Coelho Mary Theresa Director | 2023-06-09 17:13:07 | 52,000 0 | 52,000 | Form 4 |
van de Winkel Jan Director | 2023-06-09 17:14:16 | 52,000 0 | 52,000 | Form 4 |
Peters Malte Director | 2023-06-09 17:16:39 | 52,000 0 | 52,000 | Form 4 |
Kandera Reinhard Chief Financial Officer | 2023-08-22 16:01:36 | 43,092 0 | 43,092 | Form 4 |
Kaufman David Ross Director | 2023-06-09 17:13:33 | 26,000 0 | 26,000 | Form 4 |
O'Neill Julie Director | 2023-06-09 17:15:40 | 26,000 0 | 26,000 | Form 4 |
Reilly Timothy P. Director | 2023-06-09 17:16:09 | 26,000 0 | 26,000 | Form 4 |
Kelly Michael Aaron Director | 2022-07-01 16:09:41 | 20,000 0 | 20,000 | Form 4 |
Lilja Anders Sr. VP, Technical Development | 2020-01-27 16:52:34 | 13,098 0 | 13,098 | Form 4 |
Soria Jean-Charles Director | 2021-06-04 20:37:46 | 9600 0 | 9600 | Form 4 |
Lengauer Christoph Director | 2021-06-04 20:35:41 | 9600 0 | 9600 | Form 4 |
van Deventer Sander Director | 2020-10-23 16:03:48 | 2485 0 | 2485 | Form 4 |
Forbion Capital Fund II Cooperatief U.A. 10% Owner | 2022-02-11 09:18:59 | 966 0 | 966 | Form 13G |
Seghezzi Graziano Director | 2021-06-14 16:31:18 | 0 0 | 0 | Form 4/A |